Evommune annual operating margin
2024
2025
Evommune Operating Margin Growth & History (EVMN)
Evommune's operating margin was −623.62% for fiscal 2025.
View full Evommune company overviewEvommune annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −623.62% | +376.56 pp |
| 2024 | 2024-12-31 | −1,000.19% | — |
Evommune quarterly operating margin
Q1.25
Q3.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −133.28% | — |
| Q1 2025 | 2025-03-31 | −501.07% | — |
Evommune operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Evommune's operating margin increased from −1,000.19% to −623.62%, a change of +376.56 percentage points. The latest reported quarter, Q3 2025, shows −133.28%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evommune source filings ↗